These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27112167)

  • 1. Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis.
    Mahdi ZM; Synal-Hermanns U; Yoker A; Locher KP; Stieger B
    Mol Pharmacol; 2016 Jul; 90(1):23-34. PubMed ID: 27112167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
    Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
    Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3/ABCB4.
    Yoshikado T; Takada T; Yamamoto T; Yamaji H; Ito K; Santa T; Yokota H; Yatomi Y; Yoshida H; Goto J; Tsuji S; Suzuki H
    Mol Pharmacol; 2011 Feb; 79(2):241-50. PubMed ID: 21056966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells.
    Anthérieu S; Bachour-El Azzi P; Dumont J; Abdel-Razzak Z; Guguen-Guillouzo C; Fromenty B; Robin MA; Guillouzo A
    Hepatology; 2013 Apr; 57(4):1518-29. PubMed ID: 23175273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.
    Ali I; Khalid S; Stieger B; Brouwer KLR
    Mol Pharm; 2019 Mar; 16(3):1406-1411. PubMed ID: 30608704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Methoxypsoralen disrupts MDR3-mediated phospholipids efflux and bile acid homeostasis and its relevance to hepatotoxicity.
    Zhao G; Xu D; Yuan Z; Jiang Z; Zhou W; Li Z; Yin M; Zhou Z; Zhang L; Wang T
    Toxicology; 2017 Jul; 386():40-48. PubMed ID: 28552422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
    Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
    Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
    Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
    Funk C; Ponelle C; Scheuermann G; Pantze M
    Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
    Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
    Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired localisation and transport function of canalicular Bsep in taurolithocholate induced cholestasis in the rat.
    Crocenzi FA; Mottino AD; Sánchez Pozzi EJ; Pellegrino JM; Rodríguez Garay EA; Milkiewicz P; Vore M; Coleman R; Roma MG
    Gut; 2003 Aug; 52(8):1170-7. PubMed ID: 12865277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.
    Aleo MD; Shah F; He K; Bonin PD; Rodrigues AD
    Chem Res Toxicol; 2017 May; 30(5):1219-1229. PubMed ID: 28437613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
    Pauli-Magnus C; Meier PJ; Stieger B
    Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human.
    Jemnitz K; Veres Z; Vereczkey L
    Toxicol Sci; 2010 May; 115(1):80-8. PubMed ID: 20147439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump.
    Ballatori N; Rebbeor JF; Connolly GC; Seward DJ; Lenth BE; Henson JH; Sundaram P; Boyer JL
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G57-63. PubMed ID: 10644562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis.
    Burbank MG; Burban A; Sharanek A; Weaver RJ; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2016 Nov; 44(11):1780-1793. PubMed ID: 27538918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
    Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
    Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.